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Abstract
In this issue of Critical Care Chamorro-Marin and coworkers
provide new evidence that dopamine instilled into airspaces is
beneficial in a rat model of ventilator-induced lung injury. This study
is important because it is the first to explore the effects of
dopamine on survival, albeit short term. The delivery of dopamine
into the airspaces in vivo is also novel and builds upon previous
studies describing the mechanisms by which dopamine exerts its
effect by upregulating active Na+ transport in the lungs. Dopamine
appears to increase active Na+ transport via activation of amiloride-
sensitive sodium channels and the basolateral Na+/K+-ATPase
within minutes, and it has been shown to be effective in normal
lungs and several models of lung injury. This information is relevant
to current clinical trials exploring the effects of alveolar fluid
clearance stimulation in patients with acute lung injury.
In this issue of Critical Care Chamorro-Marin and coworkers
[1] reported a significant decrease in short-term ventilator-
induced lung injury (VILI)-related mortality by intratracheal
administration of dopamine in rats subjected to injurious (high
tidal volume) mechanical ventilation. This finding is interesting
and has potentially relevant implications for mechanically
ventilated patients with acute lung injury.
VILI occurs when the lung tissue is disrupted by high tidal
volumes during mechanical ventilation, leading to pulmonary
edema and hypoxemia [2]. The lung injury and edema
formation were proposed to be due to activation of intra-
cellular signals that initiate/amplify an injurious cascade that
leads to systemic inflammation and dysfunction of other organs
[2]. Many strategies have been tested with the aim being to
decrease the deleterious effects of VILI. The one approach
with more acknowledged success was that evaluated in the
the US National Institutes of Health-sponsored ARDSnet
study, which showed that ventilating patients with acute
respiratory distress syndrome with a low tidal volume strategy
(about 6 ml/kg) decreased mortality in this patient population.
Other approaches such as high levels of positive end-
expiratory pressure, prone positioning, and recruitment
maneuvers appear to improve hypoxemia but have not yet been
shown to reduce mortality [3]. Despite the incorporation of
these approaches into clinical practice, the incidence of VILI
and mortality in patients with pulmonary edema remains high.
In their study in rats, Chamorro-Marin and coworkers [1]
found that administration of dopamine in airspaces exposed
to injurious (high tidal volume) mechanical ventilation resulted
in lower lung wet weight/dry weight ratio (a gravimetric
estimate of pulmonary edema) and improved survival in the
dopamine-treated group. As such, the study provides
interesting and novel information. For example, the use of very
high levels of tidal volume which cause lung injury may
suggest that the dopamine instillation strategy could be of
benefit, particularly in patients who cannot tolerate low tidal
volume, as is the case for a small proportion of patients who
require ventilation with injuriously high tidal volumes. Also, as
shown in Table 2 of the report by Chamorro-Marin and
coworkers [1], dopamine instilled into rat airspaces did not
appear to cause deleterious hemodynamic effects, as are
sometimes observed during systemic administration of
dopamine, particularly at higher doses. A limitation of the
study is that although relevant, the research focuses on a very
short period of time and further studies would be of benefit to
validate these interesting observations. As mentioned by the
investigators, research in larger animals, reflecting the
situation in patients to a greater extent, would be of
significant interest.
An important question highlighted by this research is why and
how does dopamine exert its effects in the lungs of animal
models (and hopefully in patients)? Dopamine has been
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reported to accelerate clearance of lung edema in normal and
VILI lung models via activation of D1 and D2 receptors [4-6].
These reports demonstrated that activating dopaminergic D1
receptors increases, within minutes, Na+/K+-ATPase activity
by promoting the recruitment of Na+ pump proteins from
intracellular endosomal compartments into the plasma
membrane of alveolar epithelial cells via specific signaling
pathways that involve cell microtubules and actin cell cyto-
skeleton [7-9]. Dopamine has been also shown to activate
amiloride-sensitive Na+ channels in alveolar epithelial type I
cells, which cover most of the alveolar epithelial surface area
[10].
Interestingly, activating dopaminergic D2 receptors has a
different effect on the Na+/K+-ATPase, which includes
stimulation of mitogen-activated kinase ERK1/2 (extracellular
signal-regulated kinase-1/2), leading to increased trans-
cription/translation of the Na+/K+-ATPase proteins by 24 hours
[6]. It thus appears that dopamine, by increasing initially the
Na+/K+-ATPase protein abundance at the plasma membrane
and later by increasing protein translation, leads to higher
Na+/K+-ATPase activity and hence increased edema clearance.
The other important issue is that dopamine in this and in
some previous studies was delivered intratracheally, which
decreases the potentially confounding systemic effects, thus
offering a therapeutic alternative. The more localized approach
to delivering β-adrenergic agonists to lung epithelium has
been reported to be beneficial in patients with pulmonary
edema [11] and is now the focus of large multicenter clinical
trials. The study by Chamorro-Marin and coworkers [1]
provides further evidence, albeit in an animal model, that
direct therapy with yet another inexpensive drug (dopamine)
delivered to the lungs can be of benefit in terms of improving
oxygenation and short-term survival.
In summary, Chamorro-Marin and coworkers [1] present
interesting data in an animal model of lung injury that suggest
a beneficial effect of dopamine delivered directly to lung
epithelium, which may be applied as an adjuvant measure to
counteract the deleterious effects of VILI; those investigators
also provide valuable insight into the pathophysiology of VILI.
Delivering pharmacologic agents directly to the bronchial and
alveolar epithelium may become a valid therapeutic strategy
for treating patients with pulmonary edema and avoiding
systemic effects of compounds that are relatively inexpensive
and with which physicians are quite familiar.
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